Comparison of Two Triple Regimens for Treatment and Retreatment of Chronic Hepatitis C Infection

Clinical Trial ID NCT01771653

Rank	Title	Journal	Year	PubWeight™‹?›
1	Boceprevir for untreated chronic HCV genotype 1 infection.	N Engl J Med	2011	19.01
2	Hepatitis C virus infection.	N Engl J Med	2001	18.67
3	Telaprevir for previously untreated chronic hepatitis C virus infection.	N Engl J Med	2011	16.93
4	Boceprevir for previously treated chronic HCV genotype 1 infection.	N Engl J Med	2011	12.09
5	Telaprevir for retreatment of HCV infection.	N Engl J Med	2011	10.48
6	Telaprevir for previously treated chronic HCV infection.	N Engl J Med	2010	8.33
7	Hepatitis C-related hepatocellular carcinoma in the United States: influence of ethnic status.	Am J Gastroenterol	2003	2.18
8	An IL28B genotype-based clinical prediction model for treatment of chronic hepatitis C.	PLoS One	2011	1.04
9	Efficacy and tolerability of peginterferon alfa-2a or alfa-2b plus ribavirin in the daily routine treatment of patients with chronic hepatitis C in Germany: the PRACTICE study.	J Viral Hepat	2010	0.96
10	Granulocyte colony-stimulating factor dosing in pegylated interferon alpha-induced neutropenia and its impact on outcome of anti-HCV therapy.	J Viral Hepat	2007	0.82